Ophthalmology · Morrow, GA
NPI
1811286149
Since 2011
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1000 Corporate Center Dr, Suite 100
Morrow, GA, 30260
Phone (770) 968-8888
Groups this clinician bills Medicare through
Medicare paid, 2024
$225K
1,282 services
Medicare patients, 2024
386
Average age 74
Drug cost, 2024
$270K
1,171 prescriptions
Company payments, 2025
$1,128
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer L Kim was code 66984 (cataract surgery), 329 times for 189 patients. In total Jennifer L Kim billed 1,282 services in 26 codes, and Medicare paid $225K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 66984 Cataract Surgery | Facility | 329 | 189 | $399.13 | $131K |
| 92136 Ultrasound - Nonspecific | Office | 213 | 212 | $36.24 | $7,718 |
| 92004 Ophthalmological E&M | Office | 202 | 202 | $108.31 | $22K |
| 92014 Ophthalmological E&M | Office | 133 | 126 | $91.86 | $12K |
| 92134 Computerized Ophthalmic Imaging | Office | 93 | 85 | $28.46 | $2,646 |
| 66821 Cataract Surgery | Facility | 88 | 57 | $255.09 | $22K |
| 76514 Ultrasound - Nonspecific | Office | 45 | 45 | $8.84 | $398 |
| 92133 Computerized Ophthalmic Imaging | Office | 35 | 35 | $28.76 | $1,007 |
| 92012 Ophthalmological E&M | Office | 31 | 20 | $62.72 | $1,944 |
| 92020 Ophthalmological E&M | Office | 20 | 20 | $23.02 | $460 |
| 66982 Cataract Surgery | Facility | 19 | 14 | $570.51 | $11K |
| 99204 Office E&M - New | Office | 18 | 18 | $42.47 | $765 |
| 92286 Standard X-ray | Office | 11 | 11 | $32.80 | $361 |
By year: 2022 $250K for 1,565 services; 2023 $255K for 1,410 services; 2024 $225K for 1,282 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer L Kim prescribed most often to Medicare patients was Lotemax Sm (Loteprednol Etabonate), with 219 prescriptions and refills. In total Jennifer L Kim wrote 1,171 Medicare prescriptions that cost $270K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lotemax Sm Loteprednol Etabonate | 219 | 226 | 120 | $56K |
| Ilevro Nepafenac | 207 | 304 | 151 | $77K |
| Prednisolone Acetate Generic | 147 | 156 | 86 | $3,910 |
| Besivance Besifloxacin Hcl | 107 | 110 | 74 | $24K |
| Moxifloxacin Moxifloxacin Hcl | 99 | 100 | 68 | $2,015 |
| Prolensa Bromfenac Sodium | 93 | 139 | 71 | $33K |
| Ketorolac Tromethamine Generic | 91 | 120 | 65 | $1,176 |
| Bromfenac Sodium Generic | 54 | 73 | 41 | $10K |
| Ofloxacin Generic | 37 | 37 | 31 | $394 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 20 | 40 | 13 | $298 |
| Xiidra Lifitegrast | 19 | 43 | 13 | $29K |
| Timolol Maleate Generic | 14 | 39 | Under 11 | $123 |
| Loteprednol Etabonate Generic | 12 | 14 | 12 | $1,981 |
Brand drugs: 862 claims; generic drugs: 309 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer L Kim $1,128 ($1,128 in general payments such as food, travel and fees) from 10 companies. The largest payer was Alcon Vision LLC with $582.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 10 | $582 |
| Bausch & Lomb Americas Inc. BLCO | 4 | $173 |
| Harrow Eye, LLC | 4 | $115 |
| Abbvie Inc. ABBV | 3 | $68.32 |
| Glaukos Corporation GKOS | 2 | $50.37 |
| Oyster Point Pharma, Inc. | 2 | $37.92 |
| Grifols USA, LLC | 1 | $34.84 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $28.35 |
| Biotissue Holdings Inc. | 1 | $20.13 |
| Thea Pharma Inc. | 1 | $18.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.